vendredi 20 mars 2020

Onco Actu du 20 mars 2020


1. BIOLOGIE



A Protein That Helps Trap Bacteria May Contribute to Metastasis in a Mouse Model of Breast Cancer [AACR]











1.4 BIOLOGIE - TECHNOS, MODÈLES



New technology helps in hunt for new cancer drug combinations [Walter and Eliza Hall Institute]











2.5 ETIOLOGIE - GÉNOME



NCI study provides genetic insights into osteosarcoma in children [NCI]










4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC



Analyzing Tumor RNA May Help Match Patients with Most Effective Cancer Treatments [NCI]











4.10 DÉP., DIAG. & PRONO. - POUMON



AI may help predict responses to non-small cell lung cancer systemic therapies [EurekAlert!]











4.12 BIOPSIES LIQUIDES



Imaging Could Help ID Brain Cancer Patients Eligible for Plasma Testing [Genome Web]











5. TRAITEMENTS



Younger men with prostate cancer benefit from more aggressive treatment [UPI]











5.12.11 IMMUNOTHÉRAPIES - PRÉ-CLINIQUE



New Drug Combination Passes Safety Test in Pancreatic Cancer [Mary Ann Liebert]











5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



Eureka Partners With Lyell to Tackle Tricky Solid Tumor Cell Therapies [Xconomy]











5.12.4 IMMUNOTHÉRAPIES - ESSAIS



Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers [MD Anderson Cancer Center]










5.12.5.1 IMMUNOTHÉRAPIES - BIOTECH



Soligenix's stock climbs as phase 3 lymphoma trial hits goal [Fierce Biotech]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



Lynparza granted orphan drug designation in Japan for BRCA-mutated metastatic pancreatic cancer [AstraZeneca]











6.15 LUTTE CONTRE LES CANCERS - COVID-19



Moleculin advances plan to strip and starve COVID-19 [Fierce Biotech]











Coronavirus lockdown: What I learnt when I shut my cancer lab in 48 hours [Nature]